by Michael Benatar | Jun 9, 2021 | Events, Press Releases
Spirulina, or blue green algae, is a supplement that is claimed to have antioxidant and anti-inflammatory properties. Here we review the problems we found with the single relevant preclinical ALS study, and some surprising real and potential risks associated with this...
by Michael Benatar | Dec 11, 2020 | Events, Press Releases, Research Highlights
For more than a decade, investigators at the University of Miami Miller School of Medicine have been studying the earliest signs of amyotrophic lateral sclerosis (ALS). Now, armed with biomarkers and findings from their Pre-Symptomatic Familial ALS (Pre-fALS) study,...
by Michael Benatar | Oct 18, 2020 | Events, Press Releases, Research Highlights
The first Pre-Symptomatic ALS Workshop, organized and hosted by Dr. Michael Benatar (University of Miami), took place in Miami on January 27th, 2020. This Workshop brought together ~40 specialists in the fields of ALS, frontotemporal dementia (FTD), other...
by Michael Benatar | Sep 10, 2020 | Events, Research Highlights
To help raise awareness about rare diseases, the National Center for Advancing Translation Science (NCATS) hosts an annual ‘Rare Diseases are Not Rare’ challenge. Members of the ALS Center research team participated in this challenge. Please see below to view our...
by Michael Benatar | Sep 10, 2020 | Events, Press Releases
The ALS Center’s own Michael Benatar MD, PhD spoke on “The Future is Now: ALS Research at the University of Miami” at the 7th 2020 Hope and Help Symposium, hosted by The ALS Association Florida Chapter.
